GENEFIN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GENEFIN
Largest movements
- Cash +€1.4m
up €1.4m (+1,193%), from €121,067 to €1.6m
mainly Net result for the year (+€1.2m) and Current investments (+€536,423)
- Current investments -€536,423
down €536,423 (-18.5%), from €2.9m to €2.4m
- Reserves +€1.2m
up €1.2m (+52.7%), from €2.3m to €3.5m
of which Distributable reserves: +€1.1m
- Financial income +€66,544
up €66,544 (+5.2%), from €1.3m to €1.4m
- Financial charges -€12,451
down €12,451 (-35.4%), from €35,135 to €22,684
- Taxes +€5,634
up €5,634 (+4.5%), from €125,122 to €130,756
- Gross operating margin +€1,417
up €1,417 (+26.9%), from -€5,271 to -€3,855
- Other operating charges +€483
up €483 (+11.5%), from €4,185 to €4,668
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €27,175,620 | €28,369,599 | +€1.2m | +4.4% |
| Fixed assets | 21/28 | €23,890,761 | €23,890,761 | = | 0.0% |
| Financial fixed assets | 28 | €23,890,761 | €23,890,761 | = | 0.0% |
| Current assets | 29/58 | €3,284,859 | €4,478,839 | +€1.2m | +36.3% |
| Amounts receivable within one year | 40/41 | €261,033 | €533,365 | +€272,332 | +104% |
| Other amounts receivable | 41 | €261,033 | €533,365 | +€272,332 | +104% |
| Current investments | 50/53 | €2,899,382 | €2,362,959 | -€536,423 | -18.5% |
| Cash at bank and in hand | 54/58 | €121,067 | €1,565,022 | +€1.4m | +1,193% |
| Deferred charges and accrued income | 490/1 | €3,378 | €17,492 | +€14,115 | +418% |
| Total equity and liabilities | 10/49 | €27,175,620 | €28,369,599 | +€1.2m | +4.4% |
| Equity | 10/15 | €9,523,020 | €10,718,799 | +€1.2m | +12.6% |
| Contributions | 10/11 | €4,000,000 | €4,000,000 | = | 0.0% |
| Capital | 10 | €4,000,000 | €4,000,000 | = | 0.0% |
| Issued capital | 100 | €4,000,000 | €4,000,000 | = | 0.0% |
| Reserves | 13 | €2,268,375 | €3,464,154 | +€1.2m | +52.7% |
| Non-distributable reserves | 130/1 | €230,000 | €300,000 | +€70,000 | +30.4% |
| Legal reserve | 130 | €230,000 | €300,000 | +€70,000 | +30.4% |
| Distributable reserves | 133 | €2,038,375 | €3,164,154 | +€1.1m | +55.2% |
| Profit (loss) carried forward | 14 | €3,254,645 | €3,254,645 | = | 0.0% |
| Amounts payable | 17/49 | €17,652,600 | €17,650,800 | -€1,800 | 0.0% |
| Amounts payable within one year | 42/48 | €17,652,600 | €17,650,800 | -€1,800 | 0.0% |
| Trade debts | 44 | €1,800 | €0 | -€1,800 | -100% |
| Suppliers | 440/4 | €1,800 | €0 | -€1,800 | -100% |
| Other amounts payable | 47/48 | €17,650,800 | €17,650,800 | = | 0.0% |
| Other operating charges | 640/8 | €4,185 | €4,668 | +€483 | +11.5% |
| Gross operating margin | 9900 | -€5,271 | -€3,855 | +€1,417 | +26.9% |
| Operating profit (loss) | 9901 | -€9,456 | -€8,523 | +€934 | +9.9% |
| Financial income | 75/76B | €1,291,198 | €1,357,742 | +€66,544 | +5.2% |
| Recurring financial income | 75 | €1,291,198 | €1,357,742 | +€66,544 | +5.2% |
| Financial charges | 65/66B | €35,135 | €22,684 | -€12,451 | -35.4% |
| Recurring financial charges | 65 | €35,135 | €22,684 | -€12,451 | -35.4% |
| Profit (loss) for the period before taxes | 9903 | €1,246,606 | €1,326,535 | +€79,929 | +6.4% |
| Income taxes | 67/77 | €125,122 | €130,756 | +€5,634 | +4.5% |
| Profit (loss) for the period | 9904 | €1,121,484 | €1,195,779 | +€74,295 | +6.6% |
| Profit (loss) for the period to be appropriated | 9905 | €1,121,484 | €1,195,779 | +€74,295 | +6.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.